Suja Life, Inc. Investigation - SUJA
Case Summary
Investors who suffered a loss and would like to learn more, click here to contact us.
Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Suja Life, Inc. (NASDAQ: SUJA).
If you have information that could assist in the Suja Life investigation or if you are a Suja Life investor who suffered a loss and would like to learn more, you can provide your information in the form on this page. You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at info@rgrdlaw.com.
THE COMPANY: Suja Life engages in the production and selling of organic and cold-pressed juices and wellness shots. On May 7, 2026, Suja Life conducted its initial public offering, raising net proceeds of more than $170 million by selling 8,888,889 shares at $21.
THE REVELATION: On August 4, 2026, Suja Life reported second quarter 2026 financial results, adjusting full year 2026 net sales guidance down to $360 to $369 million “reflecting near-term softness concentrated in the grocery channel.” On this news, the price of Suja Life stock fell more than 46%.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig.